How Exercise and Geroscience Can Help You Sidestep Heart Disease and Live Longer

Cardiovascular disease kills more people worldwide than any other cause, and aging is its most powerful driver. Yet aging itself has historically been treated as an unavoidable backdrop rather than a modifiable target. This review challenges that assumption, making the case that the geroscience paradigm — targeting the biological mechanisms of aging directly — represents a transformative shift in how we approach cardiovascular and geriatric medicine.

The authors, cardiologists writing from Athens University School of Medicine, synthesize a broad landscape of age-related conditions that intersect with cardiovascular risk. These include multimorbidity, frailty, cognitive impairment, cardiac arrhythmias, coronary disease, heart failure, sarcopenia, undernutrition, and polypharmacy. Each of these is framed not as a separate disease but as a downstream consequence of the same upstream aging processes: declining cellular repair, accumulating molecular damage, and eroding physiological resilience.

A core argument of the review is that recently identified molecular resilience mechanisms represent promising new therapeutic targets. Geroscience-informed interventions, both pharmacological and nonpharmacological, could interrupt this cascade before clinical disease emerges. The authors place particular emphasis on exercise and physical activity as potent geroprotective tools, alongside healthy diets, lifestyle modification, and psychological well-being.

For clinicians, the practical implication is significant: rather than treating each age-related condition in isolation, a geroscience-centered approach to patient care could simultaneously reduce cardiovascular risk, cognitive decline, frailty, and metabolic dysfunction — compressing morbidity into a shorter window late in life.

Caveats are substantial. This is a narrative review, not a systematic one, and conclusions about specific interventions are not backed by original data. The summary is based on the abstract only, and the full paper's methodology, evidence quality, and specific recommendations cannot be assessed. The breadth of topics covered may also limit depth on any single intervention.